AlphaCentric Advisors’s Amgen AMGN Stock Holding History

AlphaCentric Advisors’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$855K	Buy	2,362 +33	+1%	+$11.3K	0.72%	35
2026 Q1	$819K	Buy	2,329 +127	+6%	+$45.3K	0.82%	26
2025 Q4	$721K	Buy	+2,202	New	+$698K	0.72%	38
2023 Q4	–	Sell	-890	Closed	-$239K	–	225
2023 Q3	$239K	Sell	890 -28	-3%	-$6.99K	0.14%	129
2023 Q2	$204K	Sell	918 -64	-7%	-$14.8K	0.11%	147
2023 Q1	$237K	Sell	982 -10	-1%	-$2.46K	0.16%	134
2022 Q4	$261K	Buy	+992	New	+$266K	0.26%	118

Other funds holding AMGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

AlphaCentric Advisors's AMGN Position: Q2 2026 in Review

AlphaCentric Advisors increased its Amgen (AMGN) stake by 1.4% in Q2 2026, buying an estimated $11.3K and bringing the position to 2,362 shares worth $855K. The position accounts for 0.72% of the portfolio, ranked #35.

AlphaCentric Advisors first reported a position in AMGN in Q4 2022 and has held it in 7 quarters since. 3,149 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

AlphaCentric Advisors held 2,362 shares of Amgen worth $855K as of Q2 2026.
AlphaCentric Advisors bought 33 Amgen shares in Q2 2026, an estimated $11.3K.
Amgen made up 0.72% of AlphaCentric Advisors's portfolio in Q2 2026, its #35 holding.
AlphaCentric Advisors first reported a position in Amgen in Q4 2022 and has held it in 7 quarters since.
3,149 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on AlphaCentric Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.